tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market
AQST
Aquestive Therapeutics
Overview
Analyst Forecasts
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Aquestive Therapeutics (AQST) Stock News & Sentiment

Compare
2,126 Followers
Optimistic Buy Rating for Aquestive Therapeutics Driven by Anaphylm NDA Submission and Strong Financial Position
Premium
Ratings
Optimistic Buy Rating for Aquestive Therapeutics Driven by Anaphylm NDA Submission and Strong Financial Position
8h ago
AQST
Aquestive Therapeutics’ Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Aquestive Therapeutics’ Earnings Call: Progress Amid Challenges
16h ago
AQST
Aquestive Therapeutics Advances Product Pipeline and Market Access
Premium
Company Announcements
Aquestive Therapeutics Advances Product Pipeline and Market Access
1d ago
8K
AQST
Buy Rating on Aquestive Therapeutics Driven by Anaphylm’s Regulatory Progress and Strategic Launch Preparations
Premium
Ratings
Buy Rating on Aquestive Therapeutics Driven by Anaphylm’s Regulatory Progress and Strategic Launch Preparations
1d ago
AQST
Aquestive Therapeutics Reports 2024 Financial Results and Strategic Progress
Premium
Company Announcements
Aquestive Therapeutics Reports 2024 Financial Results and Strategic Progress
4d ago
AQST
Aquestive Therapeutics: Strategic Advancements and Financial Strength Underpin Buy Rating
Premium
Ratings
Aquestive Therapeutics: Strategic Advancements and Financial Strength Underpin Buy Rating
5d ago
AQST
Aquestive Therapeutics Initiates Anaphylm NDA Filing Process
Premium
Company Announcements
Aquestive Therapeutics Initiates Anaphylm NDA Filing Process
6d ago
8K
AQST
More AQST News >

AQST News on the Web

Raymond James Keeps Their Buy Rating on Aquestive Therapeutics (AQST)
TipRanks News
Neutral
Aquestive Therapeutics Inc Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...
Yahoo Finance
Neutral
Compared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key Metrics
Zacks
Neutral
Aquestive Therapeutics Reports Q4 Loss, Lags Revenue Estimates
Yahoo Finance
Neutral
Aquestive Therapeutics (AQST) Reports Q4 Loss, Lags Revenue Estimates
Zacks
Bearish
Aquestive Therapeutics: Q4 Earnings Snapshot
Yahoo Finance
Neutral
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Yahoo Finance
Neutral
What To Expect From Aquestive Therapeutics Inc (AQST) Q4 2024 Earnings
GuruFocus News
Neutral

News Score - Last 7 Days

Negative
AQST
Sector Average
Media Buzz
This Week8 articles
Weekly Average3.5 articles
News Sentiment
This Week0%
Sector Average53%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AQST’s Media Buzz Sentiment?
8 articles about AQST were published this week. In an average week, 3.5 articles are published.
    What is AQST’s weekly average amount of articles?
    In an average week, 3.5 articles about AQST are published.
      What is AQST’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      JAZZJazz Pharmaceuticals
      FENCFennec Pharmaceuticals
      CKPTCheckpoint Therapeutics
      NVONovo Nordisk
      LCTXLineage Therap
      Showing the stocks with the most bullish news sentiment over the past week

      Become an Expert with TipRanks Premium

      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis
      Subscribe NowSee Plans & Pricing